Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
In this study, neuroimaging of reward processing, drug cue reactivity and inhibitory control is used before and immediately after 8 weeks of two types of group therapy in individuals with opioid addiction; clinical outcomes will be assessed before, immediately and three months after treatment. Results could point to factors that track and predict recovery with treatment, offering clinicians markers that can be used for enhancing precision medicine with the goal of reducing morbidity and mortality associated with opiate addiction.
Official title: Neuroimaging Response Inhibition and Salience Attribution Changes During Mindfulness-based Treatment of Human Heroin Addiction
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
157
Start Date
2020-06-21
Completion Date
2031-03-31
Last Updated
2025-07-03
Healthy Volunteers
Yes
Conditions
Interventions
Behavioral group therapy #1
Participants will participate in an 8-weeks of group therapy that uses psychological principles including mindfulness training, and could help decrease cravings for heroin and increase general well-being.
Behavioral group therapy #2
Participants will participate in an 8-weeks of group therapy that uses psychological principles (but not including mindfulness training) and could help decrease craving for heroin and increase general well-being.
Locations (1)
Icahn School of Medicine at Mount Sinai
New York, New York, United States